D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
HNI Corp
HNI
$3.14B
| $4.13M | 0.01% |
113,753
+17,362
| +18% | +$668K |
|
1627
American Tower
AMT
$81.3B
| $4.11M | 0.01% |
20,872
+11,989
| +135% | +$2.1M |
|
1628
Zillow
ZG
$7.79B
| $4.11M | 0.01% |
120,017
+5,769
| +5% | +$204K |
|
1629
Edgewell Personal Care
EPC
$1.26B
| $4.09M | 0.01% |
+93,287
| New | +$3.89M |
|
|
WAIR
1630
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $4.09M | 0.01% |
465,662
+214,160
| +85% | +$1.76M |
|
1631
Graham Holdings Company
GHC
$5.28B
| $4.08M | 0.01% |
5,980
-246
| -4% | -$165K |
|
1632
CALL
ArcelorMittal
MT
$52.3B
| $4.08M | 0.01% |
200,400
+181,400
| +955% | +$4.02M |
|
1633
CytomX Therapeutics
CTMX
$714M
| $4.08M | 0.01% |
379,754
+246,072
| +184% | +$3.64M |
|
1634
PUT
Avis
CAR
$5.37B
| $4.07M | 0.01% |
116,700
+24,900
| +27% | +$746K |
|
1635
FS KKR Capital
FSK
$2.96B
| $4.07M | 0.01% |
168,052
+85,889
| +105% | +$2.13M |
|
1636
Onto Innovation
ONTO
$12.5B
| $4.05M | 0.01% |
131,146
+76,617
| +141% | +$2.25M |
|
1637
Tyler Technologies
TYL
$13.3B
| $4.05M | 0.01% |
19,800
+4,175
| +27% | +$827K |
|
|
NXGN
1638
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.04M | 0.01% |
240,300
-14,499
| -6% | -$251K |
|
|
CRAY
1639
DELISTED
Cray, Inc.
CRAY
| $4.04M | 0.01% |
155,090
-65,322
| -30% | -$1.52M |
|
|
BFX
1640
DELISTED
BowFlex Inc.
BFX
| $4.04M | 0.01% |
726,298
+411,396
| +131% | +$3.18M |
|
|
SGI
1641
PUT
Somnigroup International
SGI
$14.1B
| $4.04M | 0.01% |
280,000
-120,000
| -30% | -$1.62M |
|
1642
Boot Barn
BOOT
$4.68B
| $4.03M | 0.01% |
+136,826
| New | +$3.45M |
|
1643
Coeur Mining
CDE
$15.9B
| $4.02M | 0.01% |
984,367
-1,581,149
| -62% | -$7.63M |
|
1644
Sinclair Inc
SBGI
$994M
| $4.01M | 0.01% |
104,169
-54,272
| -34% | -$1.82M |
|
1645
CALL
Norfolk Southern
NSC
$75B
| $4M | 0.01% |
21,400
-94,900
| -82% | -$16.4M |
|
|
B
1646
CALL
Barrick Mining
B
$63.2B
| $4M | 0.01% |
291,400
-36,500
| -11% | -$472K |
|
|
EV
1647
DELISTED
Eaton Vance Corp.
EV
| $3.99M | 0.01% |
99,068
-189,452
| -66% | -$7.52M |
|
1648
Materion
MTRN
$4.33B
| $3.99M | 0.01% |
69,971
+28,055
| +67% | +$1.46M |
|
1649
PUT
Newell Brands
NWL
$2.18B
| $3.99M | 0.01% |
260,200
+55,200
| +27% | +$1.01M |
|
1650
PUT
Ovintiv
OVV
$17B
| $3.99M | 0.01% |
110,244
+52,244
| +90% | +$1.79M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.